17 completed. 17 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 17 | Completed 17 |
| Phase 2 | 2 | Completed 2 |
Follow Cholangitis: new trials by email Literature Review of Cholangitis trials Research Report on Cholangitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study in Healthy Volunteers to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CS0159 CS0159 - Primary Sclerosing Cholangitis (PSC) | Phase 1 | Completed | Cascade Pharmaceuticals, Inc | 79 | 2021-10-26 | 2022-10-18 |
| Subcutaneous Doses of CM-101 as a Treatment for Medical Conditions Involving Inflammatory and Fibrotic Mechanisms in Healthy Male Subjects CM-101, Placebo - Nonalcoholic Steatohepatitis (NASH), Primary Sclerosing Cholangitis (PSC) | Phase 1 | Completed | ChemomAb Ltd. | 8 | 2019-03-05 | 2023-09-14 |
| A Study Evaluating the Safety and Efficacy of Curcumin in Patients With Primary Sclerosing Cholangitis (PSC) Curcumin - Primary Sclerosing Cholangitis | Phase 1 / Phase 2 | Completed | John E. Eaton | 15 | 2017-06-09 | 2020-01-18 |
| A Study of HTD1801 in Healthy Subjects HTD1801 - Primary Sclerosing Cholangitis | Phase 1 | Completed | HighTide Therapeutics (Hong Kong) Limited | 32 | 2017-03-24 | 2026-08-11 |
| Pharmacokinetics and Pharmacodynamics of Cilofexor in Adults With Normal and Impaired Hepatic Function Cilofexor - Nonalcoholic Steatohepatitis (NASH), Primary Sclerosing Cholangitis (PSC) | Phase 1 | Completed | Gilead Sciences | 57 | 2016-07-13 | 2021-01-07 |
| Fecal Microbiota Transplantation for the Treatment of Primary Sclerosing Cholangitis. Fecal Microbiota Transplantation - Sclerosing Cholangitis | Phase 1 / Phase 2 | Completed | Brigham and Women's Hospital | 10 | 2016-02-01 | 2019-08-28 |
| A Pilot Study to Characterize Bile Acid Metabolism and Dysbiosis in Primary Sclerosing Cholangitis Vancomycin - Primary Sclerosing Cholangitis, Inflammatory Bowel Disease | Phase 1 | Completed | University of Minnesota | 8 | 2015-07-01 | 2020-07-17 |
| Biliary Excretion of Conjugated Bile Acids in Humans Measured by 11C-cholylsarcosine PET/CT 11C-CSar, ICG - Cholestasis, Primary Sclerosing Cholangitis | Phase 1 | Completed | University of Aarhus | 22 | 2013-06-01 | 2015-02-23 |
| A Pilot Study of Xifaxan to Treat Patients With PSC Xifaxan - Primary Sclerosing Cholangitis (PSC) | Phase 1 | Completed | Mayo Clinic | 16 | 2012-08-01 | 2014-10-15 |
| Combination Therapy With Ursodeoxycholic Acid (UDCA) and All-Trans Retinoic Acid (ATRA) for Treatment of Primary Sclerosing Cholangitis Oral all-trans retinoic acid (ATRA) - Cholangitis, Sclerosing | Phase 1 | Completed | Yale University | 19 | 2011-10-01 | 2016-07-14 |
| Safety and Efficacy Study of Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis ursodeoxycholic acid (UDCA) - Primary Sclerosing Cholangitis | Phase 1 | Completed | University of Tennessee | 27 | 2010-10-01 | 2017-10-26 |
| A Pilot Study of Vancomycin or Metronidazole in Patients With Primary Sclerosing Cholangitis Vancomycin, Metronidazole - Primary Sclerosing Cholangitis | Phase 1 | Completed | Mayo Clinic | 35 | 2010-02-01 | 2013-09-19 |
| Erlotinib for Chemoprevention in Trisomy 7 Positive Primary Sclerosing Cholangitis (PSC) Erlotinib (Tarceva) - Primary Sclerosing Cholangitis, Trisomy 7 | Phase 1 | Completed | Mayo Clinic | 6 | 2009-08-01 | 2014-01-10 |
| Gastrointestinal Microbiota in Primary Sclerosing Cholangitis and Biliary Atresia With Vancomycin Vancomycin - Primary Sclerosing Cholangitis, Biliary Atresia | Phase 1 | Completed | Stanford University | 32 | 2007-05-01 | 2016-05-18 |
| Evaluation of DHA for the Treatment of PSC Docosahexaenoic Acid (DHA) - Primary Sclerosing Cholangitis, Colitis | Phase 1 | Completed | Beth Israel Deaconess Medical Center | 10 | 2005-12-01 | 2015-03-11 |
| Minocycline in Primary Sclerosing Cholangitis (PSC) Minocycline - Primary Sclerosing Cholangitis | Phase 1 | Completed | Mayo Clinic | 16 | 2003-02-01 | 2010-12-07 |
| Pilot Study of Budesonide for Patients With Primary Sclerosing Cholangitis budesonide - Cholangitis, Sclerosing, Liver Cirrhosis, Biliary | Phase 1 | Completed | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 22 | 1997-05-01 | 2017-05-31 |
Cholangitis, Sclerosing (17) · Fibrosis (2) · Liver Cirrhosis, Biliary (2) · Non-alcoholic Fatty Liver Disease (2) · Biliary Atresia (1) · Cholangiocarcinoma (1) · Cholestasis (1) · Colitis (1) · Gastrointestinal Diseases (1) · Hepatitis, Autoimmune (1) · Inflammatory Bowel Diseases (1) · Rare Diseases (1) · Scleroderma, Systemic (1)
Bile Duct Diseases (17) · Biliary Tract Diseases (17) · Digestive System Diseases (17) · Liver Diseases (5) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Cholestasis, Intrahepatic (2) · Fatty Liver (2) · Gastroenteritis (2) · Gastrointestinal Diseases (2) · Intestinal Diseases (2) · Liver Cirrhosis (2) · Adenocarcinoma (1) · Autoimmune Diseases (1)
Vancomycin (3) · Budesonide (1) · Curcumin (1) · Docosahexaenoic Acids (1) · Erlotinib Hydrochloride (1) · Fecal Microbiota Transplantation (1) · Fish Oils (1) · Indocyanine Green (1) · Metronidazole (1) · Minocycline (1) · Rifaximin (1) · Tretinoin (1) · Ursodeoxycholic Acid (1) · cholylsarcosine (1) · cilofexor (1)
Mayo Clinic (4) · Beth Israel Deaconess Medical Center (1) · Brigham and Women's Hospital (1) · Cascade Pharmaceuticals, Inc (1) · ChemomAb Ltd. (1) · Gilead Sciences (1) · HighTide Therapeutics (Hong Kong) Limited (1) · John E. Eaton (1) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1) · Stanford University (1) · University of Aarhus (1) · University of Minnesota (1) · University of Tennessee (1) · Yale University (1)
United States (13) · Australia (1) · Denmark (1) · Israel (1) · New Zealand (1)
Arnon Aharon, MD (1) · Benjamin Shneider, M.D. (1) · Byron P Vaughn, MD (1) · Dennis D Black, M.D. (1) · James L Boyer, MD (1) · Janet Wong, Doctor (1) · Jayant A Talwalkar, MD (1) · Jayant Talwalkar, MD (1) · Joshua Korzenik, MD (1) · Kathleen Doisy, MD (1) · Keith D. Lindor (1) · Keith D. Lindor, M.D. (1) · Kenneth L Cox, MD (1) · Nicholas F LaRusso, M.D. (1)
PMID 10655252, PMID 23054338, PMID 23384404, PMID 24914504, PMID 28249726, PMID 32633158, PMID 42271063
R03DK052344 (1), R03DK071851 (1)